CanSino: Convidecia Air

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Ad5-nCoV-IH

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 0 Trials

There are no trials for this phase.

Phase 3: 5 Trials

Approvals

2 Countries

Registered Trials